Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/31944
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18074/20272 (89%)
造訪人次 : 4122491      線上人數 : 5895
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31944


    標題: 費氏麴菌二次代謝物對人類大腸直腸癌細胞株之影響
    Effects of secondary metabolites from Neosartorya fischeri on human colorectal adenocarcinoma cell line
    作者: 葉昱彤
    貢獻者: 生物科技系
    田乃月
    劉坤湘
    關鍵字: 費氏麴菌
    乙醯基環帶麴菌素
    人類大腸直腸癌
    微陣列分析
    即時定量聚合酶鏈鎖反應
    p53路徑
    acetylaszonalenin
    Neosartorya fischeri
    human colorectal adenocarcinoma cells
    microarray analysis
    quantitative real-time polymerase chain reaction
    p53 signaling pathway
    日期: 2018
    上傳時間: 2019-02-27 16:49:24 (UTC+8)
    摘要: 絲狀真菌具有產生多樣結構與各種生物活性的二次代謝物之能力,如抗細菌、抗真菌及抗腫瘤等生物活性,應用在生物技術、食品加工和醫藥化學等領域。費氏麴菌在分類學上屬於新薩托屬,是一種嗜熱菌,被發現存在於潮濕土壤中,是導致水果腐敗的原因之一。費氏麴菌主要二次代謝物為乙醯基環帶麴菌素,由ana基因叢集所表現的anaPS、anaAT與anaPT三種酵素催化產生,但有關於乙醯基環帶麴菌素生物活性的相關文獻則相當稀少。由於乙醯基環帶麴菌素生合成路徑的中間產物具有抗腫瘤活性,因此合理推測乙醯基環帶麴菌素可能具有類似或是新的生物活性。為驗證乙醯基環帶麴菌素的抗腫瘤活性,本研究選擇我國國人罹患率甚高的人類大腸直腸癌,以細胞株模式做為抗腫瘤試驗對象。
    本研究首先以優化培養條件使費氏麴菌產生出較多的乙醯基環帶麴菌素,自發酵液純化出該化合物,以不同濃度進行細胞毒性測試,發現其具有毒殺人類大腸直腸癌細胞的活性。以人類全基因體晶片進行微陣列分析,結果發現可能主要經由p53路徑造成毒殺癌細胞。再以即時定量聚合酶鏈鎖反應針對p53路徑數個目標基因分析表現情形,發現ATM、p53、caspase-8與caspase-3基因表現增加,CHK2基因表現下降,此結果提供未來深入了解乙醯基環帶麴菌素的分子作用機制,以期未來可應用於抗癌藥物的開發。
    Filamentous fungi produce secondary metabolites with distinct structures and various biological activities for a wide range in biotechnology, food, and medical fields such as antibacterial, antifungal, and antitumor activity and used in different fields. Neosartorya fischeri is a heat-resistant mold frequently reported to cause spoilage in fruit products. Acetylaszonalenin is found to be the major secondary metabolite in N. fischeri, and catalyzed by anaPS, anaPT as well as anaAT encoded by a putative acetylaszonalenin-biosynthetic gene cluster. Even though this gene cluster was identified in N. fischeri, no reports on bioactivities of acetylaszonalenin could be found until now. Cause the precursor, benzodiazepinedione of acetylaszonalenin biosynthetic pathway whose antitumor activity was verified, we conjecture that acetylaszonalenin might have antitumor activity. To elucidate the antitumor activity of acetylaszonalenin, we used human colorectal adenocarcinoma cells as antitumor test object. We performed cell viability assay with various concentrations of acetylaszonalenin purified from mycelial liquid culture of N. fischeri. The results indicated that there is cytotoxicity when human colorectal adenocarcinoma cells were tested after 24- , 48- and 72-hour treatments. To better understand the molecular mechanisms involved in the response of human colorectal adenocarcinoma cells to acetylaszonalenin, microarray analysis was used to help identify significantly expressed genes that may contribute to the response. After obtaining a large-scale survey of the variations in gene expression patterns and gene ontology enrichment analysis, the p53 signaling pathway would be the first pathway to be clarified at present. These results could provide insight information into the molecular mechanisms of the antitumor activity of acetylaszonalenin.
    關聯: 電子全文公開日期:2023-09-10,學年度:106, 67頁
    顯示於類別:[生物科技系(所)] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1276檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋